Growth Metrics

CapsoVision (CV) Return on Assets (2025)

CapsoVision recorded quarterly Return on Assets of 0.01% in Q4 2025, up 14.07% quarter-over-quarter from 0.01% in Q3 2025.

CapsoVision's Return on Assets history runs 1 years deep, the most recent figure standing at 0.01% for Q4 2025.

  • In Q4 2025, Return on Assets changed N/A year-over-year to 0.01%; the TTM figure through Dec 2025 stood at 0.01% (changed N/A YoY), while the FY2025 annual figure was 0.01%, changed N/A from the prior year.
  • Return on Assets came in at 0.01% for Q4 2025 at CapsoVision, up from 0.01% in the prior quarter.
  • In the past five years, Return on Assets ranged from a high of 0.01% in Q4 2025 to a low of 0.02% in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 0.00%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 0.00%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 0.00%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 0.00%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 0.00%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 0.00%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 0.00%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 0.00%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -
10 CapsoVision 167.59 Mn 157.48 Mn 1.95 Mn -0.01%

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 -0.01%
Sep 30, 2025 -0.01%
Jun 30, 2025 -0.02%